TipRanks
Insight Molecular Diagnostics (DE:7OC0)
FRANKFURT:7OC0
Germany Market
7OC0
Insight Molecular Diagnostics
RESEARCH TOOLSreports

Insight Molecular Diagnostics (7OC0) Stock News & Sentiment

1 Followers
Insight Molecular Diagnostics Revises Chronix Royalty Agreement Terms
Premium
Company Announcements
Insight Molecular Diagnostics Revises Chronix Royalty Agreement Terms
19d ago
8K
IMDX
Insight Molecular Diagnostics Earnings Call Balances Risk
Premium
Company Announcements
Insight Molecular Diagnostics Earnings Call Balances Risk
2M ago
IMDX
Insight Molecular Diagnostics: Buy Rating Reiterated on Growing Clinical Adoption of Donor-Derived cfDNA Testing and Unchanged $9 Price Target
Premium
Ratings
Insight Molecular Diagnostics: Buy Rating Reiterated on Growing Clinical Adoption of Donor-Derived cfDNA Testing and Unchanged $9 Price Target
2M ago
IMDX
Michael Matson Reiterates Buy on IMDX, Citing Regulatory Progress, GraftAssure Platform Expansion, and Solid Cash Runway Ahead of Expected 2026 De Novo Approval
Premium
Ratings
Michael Matson Reiterates Buy on IMDX, Citing Regulatory Progress, GraftAssure Platform Expansion, and Solid Cash Runway Ahead of Expected 2026 De Novo Approval
2M ago
IMDX
Insight Molecular Nears FDA Authorization for GraftAssureDx Assay
Premium
Company Announcements
Insight Molecular Nears FDA Authorization for GraftAssureDx Assay
2M ago
8K
IMDX
IMDX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
IMDX Earnings this Week: How Will it Perform?
2M ago
IMDX
GALACTIC Trial: IMDX Advances Non‑Invasive Kidney Transplant Monitoring
Premium
Company Announcements
GALACTIC Trial: IMDX Advances Non‑Invasive Kidney Transplant Monitoring
2M ago
IMDX
More DE:7OC0 News >

7OC0 News on the Web

Insight Molecular Diagnostics Earnings Call Balances Risk
TipRanks News
Neutral
Insight Molecular Diagnostics Shareholders Back Board and Incentive Plan
TipRanks News
Neutral
Insight Molecular Diagnostics Balances Progress and Cash Burn
TipRanks News
Neutral
Analysts Have Conflicting Sentiments on These Healthcare Companies: Aquestive Therapeutics (AQST), Sangamo Therapeutics (OtherSGMO) and Insight Molecular Diagnostics (IMDX)
TipRanks News
Neutral
OncoCyte’s Earnings Call Maps Risky Path to Launch
TipRanks News
Neutral
Lake Street Remains a Buy on Insight Molecular Diagnostics (IMDX)
TipRanks News
Bullish
Insight Molecular Diagnostics Maintained at Buy as GraftAssure Platform Gains Traction; $9 Price Target Reaffirmed
TipRanks News
Bullish
Insight Molecular Diagnostics Inc (IMDX) Q1 2026 Earnings Call Highlights: Strategic Advances ...
GuruFocus News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0.25 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:7OC0’s Media Buzz Sentiment?
Currently, no data Available
What is DE:7OC0’s weekly average amount of articles?
In an average week, 0.25 articles about DE:7OC0 are published.
    What is DE:7OC0’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    CMXHFCSL
    RZLTRezolute
    AMGNAmgen
    PMCUFPro Medicus Limited
    ABTAbbott Laboratories
    Showing the stocks with the most bullish news sentiment over the past week